These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33302222)

  • 1. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
    Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
    Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
    Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
    Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation NKX2.2 IHC and
    Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
    Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
    Lee AF; Hayes MM; Lebrun D; Espinosa I; Nielsen GP; Rosenberg AE; Lee CH
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):233-8. PubMed ID: 21084965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
    Chen W; Hornick JL; Fletcher CDM
    Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and diagnostic value of NKX3.1 and NKX2.2 in mesenchymal chondrosarcoma].
    Wang XX; Chen H; Wang X; Ma L; Cheng K; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):114-119. PubMed ID: 35152629
    [No Abstract]   [Full Text] [Related]  

  • 9. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
    Devaney K; Vinh TN; Sweet DE
    Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
    Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
    Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
    Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
    Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
    Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
    Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
    Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
    Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
    Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
    Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
    Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing sarcoma and Ewing-like tumors.
    Sbaraglia M; Righi A; Gambarotti M; Dei Tos AP
    Virchows Arch; 2020 Jan; 476(1):109-119. PubMed ID: 31802230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD99 reactivity in mesenchymal chondrosarcoma.
    Granter SR; Renshaw AA; Fletcher CD; Bhan AK; Rosenberg AE
    Hum Pathol; 1996 Dec; 27(12):1273-6. PubMed ID: 8958297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
    Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
    Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of NKX3-1 Expression in EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma Using Monoclonal Antibody Immunohistochemistry, RT-PCR, and RNA In Situ Hybridization.
    Yoshida A; Hashimoto T; Ryo E; Yoshida KI; Motoi T; Yatabe Y; Mori T
    Am J Surg Pathol; 2021 Apr; 45(4):578-582. PubMed ID: 33443863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.